Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization

High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles

(2016) Rui Kuai et al.   ACS Nano

ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers

(2016) Charles L. Bisgaier et al.   PHARMACOLOGICAL RESEARCH

Reconstituted high-density lipoprotein can elevate plasma alanine aminotransferase by transient depletion of hepatic cholesterol: role of the phospholipid component

(2015) Eva Herzog et al.   JOURNAL OF APPLIED TOXICOLOGY

The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties

(2015) Anna Schwendeman et al.   JOURNAL OF LIPID RESEARCH

Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA

(2015) Ruud S. Kootte et al.   JOURNAL OF LIPID RESEARCH

CSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy Subjects

(2014) Andreas Gille et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Novel Therapies Focused on the High-Density Lipoprotein Particle

(2014) Julian C. van Capelleveen et al.   CIRCULATION RESEARCH

Inhibition of Arthritis in the Lewis Rat by Apolipoprotein A-I and Reconstituted High-Density Lipoproteins

(2013) Ben J. Wu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis

(2013) Oleg F. Sharifov et al.   PLoS One

An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice

(2012) Shu-Chen Lu et al.   JOURNAL OF LIPID RESEARCH

The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins

(2011) Belinda A. Di Bartolo et al.   ATHEROSCLEROSIS

Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits

(2011) Atsushi Iwata et al.   ATHEROSCLEROSIS

Anti-inflammatory effects of apolipoprotein A-I in the rabbit

(2010) Sanjay Patel et al.   ATHEROSCLEROSIS

A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice

(2010) John K. Bielicki et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents

(2010) David O. Osei-Hwedieh et al.   PHARMACOLOGY & THERAPEUTICS

Pathways by Which Reconstituted High-Density Lipoprotein Mobilizes Free Cholesterol From Whole Body and From Macrophages

(2009) Marina Cuchel et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Small Discoidal Pre-β1 HDL Particles Are Efficient Acceptors of Cell Cholesterol via ABCA1 and ABCG1

(2009) Elda Favari et al.   BIOCHEMISTRY

Using pharmacokinetic–pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics

(2008) Christina Kurre Olsen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Characterization and properties of preβ-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I

(2008) Phu T. Duong et al.   JOURNAL OF LIPID RESEARCH